[{"address1": "4300 El Camino Real", "address2": "Suite 210", "city": "Los Altos", "state": "CA", "zip": "94022", "country": "United States", "phone": "650 351 4495", "website": "https://unicycive.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Unicycive Therapeutics, Inc., a biotechnology company, develops treatments for various medical conditions in the United States. Its drug candidates include UNI 494, a pro-drug of Nicorandil that is being developed as a treatment for acute kidney injury; and Renazorb (Oxylanthanum Carbonate), which is being developed for the treatment of hyperphosphatemia in patients with chronic kidney disease. Unicycive Therapeutics, Inc. has license agreements with Shilpa Medicare Ltd; Sphaera Pharma Pte. Ltd.; Syneos Health LLC; Inotiv; Lee's Pharmaceutical (HK) Limited; Celerion; and Lotus International Pte Ltd. The company was incorporated in 2016 and is based in Los Altos, California.", "fullTimeEmployees": 14, "companyOfficers": [{"maxAge": 1, "name": "Dr. Shalabh K. Gupta M.D., MPA", "age": 51, "title": "Founder, Chairman, CEO & President", "yearBorn": 1973, "fiscalYear": 2023, "totalPay": 1100000, "exercisedValue": 0, "unexercisedValue": 141224}, {"maxAge": 1, "name": "Dr. Pramod  Gupta Ph.D.", "age": 64, "title": "Executive Vice President of Pharmaceutical & Business Operations", "yearBorn": 1960, "fiscalYear": 2023, "totalPay": 675000, "exercisedValue": 0, "unexercisedValue": 40969}, {"maxAge": 1, "name": "Mr. Douglas  Jermasek M.B.A.", "age": 62, "title": "Executive Vice President of Corporate Strategy", "yearBorn": 1962, "fiscalYear": 2023, "totalPay": 412500, "exercisedValue": 0, "unexercisedValue": 42029}, {"maxAge": 1, "name": "Mr. John W. Townsend CPA", "age": 62, "title": "Chief Financial Officer", "yearBorn": 1962, "fiscalYear": 2023, "totalPay": 197864, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1703980800, "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 0.5948, "open": 0.5948, "dayLow": 0.5901, "dayHigh": 0.68, "regularMarketPreviousClose": 0.5948, "regularMarketOpen": 0.5948, "regularMarketDayLow": 0.5901, "regularMarketDayHigh": 0.68, "payoutRatio": 0.0, "beta": 2.252, "forwardPE": -3.334, "volume": 1465781, "regularMarketVolume": 1465781, "averageVolume": 982756, "averageVolume10days": 478340, "averageDailyVolume10Day": 478340, "bid": 0.6466, "ask": 0.66, "bidSize": 5, "askSize": 5, "marketCap": 69211176, "fiftyTwoWeekLow": 0.202, "fiftyTwoWeekHigh": 1.6, "priceToSalesTrailing12Months": "Infinity", "fiftyDayAverage": 0.60184, "twoHundredDayAverage": 0.53078, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 30198102, "profitMargins": 0.0, "floatShares": 54692402, "sharesOutstanding": 103796000, "sharesShort": 1399359, "sharesShortPriorMonth": 823318, "sharesShortPreviousMonthDate": 1738281600, "dateShortInterest": 1740700800, "sharesPercentSharesOut": 0.0135, "heldPercentInsiders": 0.06122, "heldPercentInstitutions": 0.60393, "shortRatio": 1.4, "shortPercentOfFloat": 0.014400001, "impliedSharesOutstanding": 103796000, "bookValue": 0.285, "priceToBook": 2.3396492, "lastFiscalYearEnd": 1703980800, "nextFiscalYearEnd": 1735603200, "mostRecentQuarter": 1727654400, "netIncomeToCommon": -24097000, "trailingEps": -0.46, "forwardEps": -0.2, "enterpriseToEbitda": -1.036, "52WeekChange": -0.5809859, "SandP52WeekChange": 0.07465422, "quoteType": "EQUITY", "currentPrice": 0.6668, "targetHighPrice": 9.0, "targetLowPrice": 2.0, "targetMeanPrice": 5.5, "targetMedianPrice": 5.5, "recommendationKey": "none", "numberOfAnalystOpinions": 6, "totalCash": 32347000, "totalCashPerShare": 0.312, "ebitda": -29151000, "totalDebt": 807000, "quickRatio": 3.093, "currentRatio": 3.608, "totalRevenue": 0, "debtToEquity": 2.898, "revenuePerShare": 0.0, "returnOnAssets": -0.62847, "returnOnEquity": -1.4705299, "grossProfits": 0, "freeCashflow": -22025376, "operatingCashflow": -26466000, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": 0.0, "financialCurrency": "USD", "symbol": "UNCY", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "corporateActions": [], "regularMarketTime": 1742411419, "exchange": "NCM", "messageBoardId": "finmb_605176729", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "marketState": "REGULAR", "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1626096600000, "regularMarketChangePercent": 12.104914, "regularMarketPrice": 0.6668, "shortName": "Unicycive Therapeutics, Inc.", "longName": "Unicycive Therapeutics, Inc.", "twoHundredDayAverageChange": 0.13602, "twoHundredDayAverageChangePercent": 0.25626436, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "ipoExpectedDate": "2021-07-13", "cryptoTradeable": false, "regularMarketChange": 0.07200003, "regularMarketDayRange": "0.5901 - 0.68", "fullExchangeName": "NasdaqCM", "averageDailyVolume3Month": 982756, "fiftyTwoWeekLowChange": 0.4648, "fiftyTwoWeekLowChangePercent": 2.30099, "fiftyTwoWeekRange": "0.202 - 1.6", "fiftyTwoWeekHighChange": -0.9332, "fiftyTwoWeekHighChangePercent": -0.58325, "fiftyTwoWeekChangePercent": -58.09859, "epsTrailingTwelveMonths": -0.46, "epsForward": -0.2, "epsCurrentYear": -0.51, "priceEpsCurrentYear": -1.307451, "fiftyDayAverageChange": 0.06496, "fiftyDayAverageChangePercent": 0.10793567, "displayName": "Unicycive Therapeutics", "trailingPegRatio": null, "__fetch_time": "2025-03-19"}]